Tonghua Golden-Horse Stock Hits Day Low Amid Price Pressure at CNY 18.29

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. has experienced a significant decline today, with the stock dropping by 6.39% as of March 23, 2026. The stock reached an intraday low of CNY 18.29, reflecting ongoing challenges within the company. In terms of performance metrics, the company's one-week performance stands at a decrease of 12.59%, while the one-month performance shows a decline of 21.75%. Year-to-date, Tonghua Golden-Horse has seen a substantial drop of 32.85%. Despite a positive annual performance of 3.36%, the stock's longer-term trends reveal a stark contrast, with a remarkable 259.14% increase over three years and an impressive 388.36% rise over five years. Financially, the company is characterized by a low Return on Capital Employed (ROCE) of 2.62% and a Return on Equity (ROE) of 2.48%, indicating challenges in profitability. Additionally, the company has a high Debt to Equity ratio, which raises concerns about its long-term growth potential. Overall, the current market position of Tonghua Golden-Horse reflects a complex landscape influenced by various financial metrics and performance indicators.